Development of Novel Murine BRAFV600E-Driven Papillary Thyroid Cancer Cell Lines for Modeling of Disease Progression and Preclinical Evaluation of Therapeutics is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R01CA214511
NIH
Grant: T32GM008562
NIEHS NIH HHS
Grant: P30 ES013508
National Institutes of Health
Grant: 3R01CA214511-06S1
MAPK pathway modulation in thyroid tumorigenesis
National Institutes of Health
Grant: 5T32GM008562-12
Clinical Pharmacology Training Program
Children’s Hospital of Philadelphia Frontier Program
FWCI
0.30
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals